Trulieve Cannabis (TRLV) Common Equity (2020 - 2026)

Trulieve Cannabis has reported Common Equity for 7 years, with the latest figure at $765.9 million in Q2 2026.

• On a quarterly basis, Common Equity fell 36.67% year-over-year to $765.9 million in Q2 2026; TTM through Jun 2026 was $765.9 million, a 36.67% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 8.49% from the prior year.
• Common Equity was $765.9 million for Q2 2026 at Trulieve Cannabis, down from $1.1 billion in the prior quarter.
• The five-year high for Common Equity was $2.1 billion in Q2 2022, with the low at $765.9 million in Q2 2026.
• Average Common Equity over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Common Equity soared 336.42% in 2022, then slumped 36.67% in 2026.
• Over 5 years, Common Equity stood at $1.9 billion in 2022, then dropped by 26.93% to $1.4 billion in 2023, then slipped by 11.33% to $1.2 billion in 2024, then fell by 8.49% to $1.1 billion in 2025, then sank by 32.99% to $765.9 million in 2026.
• The last three Common Equity figures came in at $765.9 million (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.